source
- FTC sues Hims & Hers over alleged privacy violations, deceptive billing practicesRegulators say the telehealth company illegally shared patients’ health data with advertisers and misled its customers. Hims & Hers hit back, calling the claims “baseless.”BioPharma Dive · 14m ago↗ source
- J&J nabs option to buy ‘in vivo’ CAR-T maker Sail for nearly $2.6BThe deal with the buzzy Flagship Pioneering-backed startup makes J&J the latest large drugmaker to bet that the technology might be able to treat autoimmune conditions.BioPharma Dive · 25m ago↗ source
- FDA reviewers doubt Replimune’s melanoma therapy as shares tumble 40%Replimune's shares fell nearly 40% after FDA reviewers released briefing documents expressing skepticism about its experimental melanoma drug RP1. RP1 has been rejected twice before; the company l…